March 12, 2026The Pediatric Infectious Disease Journal0 citations

Invasive Meningococcal Disease in Australian Children 2016–2022: A Multicenter, Prospective Surveillance Study of Serogroup Distribution and Clinical Presentation in the Meningococcal Vaccine Era

MWMaya WositzkyPrincess Margaret Hospital for Children JLJennie LouiseWomen's and Children's Health Network NDNatascha D’AngeloWomen's and Children's Hospital

Key Result

Invasive meningococcal disease remains a significant issue, especially in socioeconomically disadvantaged and Aboriginal children, highlighting the need for improved vaccine uptake.

Key Points

To examine the serogroup distribution and clinical presentation of invasive meningococcal disease in children during the vaccine era.
Conducted a multicenter, prospective surveillance study
Monitored cases of invasive meningococcal disease from 2016 to 2022
Focused on socioeconomically disadvantaged and Indigenous children
Highlighted the continued incidence of MenB disease among children
Emphasized the need for earlier recognition and treatment to lower health risks
Identified a need to enhance vaccine uptake and availability

Structured PICO

Population

Australian children, particularly socioeconomically disadvantaged and Aboriginal and Torres Strait Islander children

Outcome

Serogroup distribution and clinical presentation of invasive meningococcal disease

There is a continued burden of MenB disease in Australian children, particularly in vulnerable populations, highlighting the need for improved vaccine uptake.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

This study highlights the continued burden of MenB disease, particularly among socioeconomically disadvantaged and Aboriginal and Torres Strait Islander children, underscores the importance of earlier recognition and treatment to reduce morbidity and mortality, and emphasizes the need for improving vaccine uptake and vaccine availability.

Demander à l'IA

Bookmark

View Full Paper